spacer
home > ict > autumn 2016 > what is the risk?
PUBLICATIONS
International Clinical Trials

What Is The Risk?

Access to high-quality, real time data is the driver behind risk-based monitoring (RBM) – a methodology used to enhance subject safety and data quality, and to deliver significant efficiency benefits. An RBM approach replaces the in-person, 100% source data verification (SDV) process based on the identification of risks and issues. Its use in clinical trials is increasing as sponsors begin to realise the potential to improve the quality of data while, at the same time, reducing total trial costs by an estimated15-20% (1). This approach is also in line with the push from regulatory authorities in the US and EU for targeted monitoring, as it is more effective than spreading resources equally across all sites.

However, managing and analysing all clinical data during the study – to identify potential current issues and future risks – is a complex speciality, which becomes particularly challenging in global, multi-site trials. Large pharmaceutical companies and CROs may have entire departments devoted to this, but that kind of scope and expertise is expensive and, for many small- and midsized biopharmaceutical and device organisations developing a product on a budget, it simply may not be an option.

Aligning these smaller teams with affordable and robust technologies, which enable the adoption of a risk-based approach to study monitoring, creates cost efficiencies that can significantly benefit them without compromising data value or patient safety.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Greg Ambra is Vice President of Clinical Operations at DZS Clinical Services. With nearly 20 years of experience in the clinical research industry, he has held strategic leadership positions in various sponsor and CRO companies. Greg has led DZS Clinical Services since 2012, and earned his Master’s degree in Medical Sciences from Boston University, US.

As Senior Director of Biostatistics, Jean Battikha has worked in the pharma industry as a statistician for nearly 40 years. He has been involved in the design, analysis and reporting of many clinical trials across several therapeutic areas, as well as with many NDA submissions in both the US and EU.
spacer
Greg Ambra
spacer
spacer
spacer
Jean Battikha
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Pharmaceutical Packaging and Labelling Summit in Zurich; ACG presentation

At next week’s Pharmaceutical Packaging and Labelling Summit in Zurich (18-19 June), Dr. Eugen Hertel from ACG will be speaking on: Challenges for Global Pharma companies to Implement Anti-Counterfeit Strategy for Russian Track & Trace Regulation. This presentation will include details around ‘the fight against counterfeit medicine - there have been and still are worldwide initiatives to make the supply chain and the safety of medicines secure. After large markets such as the USA and Europe passed their laws and regulations for the pharmaceutical manufacturing companies and established the IT infrastructure, Russia is now next on the move.
More info >>

White Papers

Autoinjector testing made safe efficient and flexible

ZwickRoell

The autoinjector market is one of the fastest growing markets across almost all pharmaceutical applications. Studies expect a global market volume of approximately USD 2.5 billion by 2020, with pre-filled autoinjectors representing the largest market segment. There are a variety of tests that can be performed on autoinjectors, and these are well-demonstrated by the Zwick product portfolio. The Ulm-based company and specialist in testing systems offers a variety of testing systems that are already being successfully used by multiple pharmaceutical companies.
More info >>

 
Industry Events

CPhI & P-MEC China

18-20 June 2019, SNIEC, Shanghai, China

CPhI & P-MEC China 2019 is your gateway to successfully grow your business at the 2nd largest pharma market in the world. Whether you are looking for sourcing new business or getting the latest market insight, this is your one-stop shop pharmaceutical platform in Asia.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement